PVLA

Palvella Therapeutics
PVLA

Upgrade to unlock
Buy
Hold
Sell

12 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$180
73% upside
High target

12 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Mizuho
Mizuho
Graig Suvannavejh
100% 1-yr PVLA win rate
7 Jan ‘26 9 days ago
Truist Securities
Truist Securities
Danielle Brill
100% 1-yr PVLA win rate
16 Dec ‘25 1 month ago
Canaccord Genuity
Canaccord Genuity
Whitney Ijem
75% 1-yr PVLA win rate
16 Dec ‘25 1 month ago
TD Cowen
TD Cowen
Ritu Baral
100% 1-yr PVLA win rate
16 Dec ‘25 1 month ago
Chardan Capital
Chardan Capital
Geulah Livshits
100% 1-yr PVLA win rate
16 Dec ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Andrew Fein
86% 1-yr PVLA win rate
15 Dec ‘25 1 month ago
BTIG
BTIG
Jeet Mukherjee
100% 1-yr PVLA win rate
15 Dec ‘25 1 month ago
Clear Street
Clear Street
Kaveri Pohlman
100% 1-yr PVLA win rate
5 Dec ‘25 1 month ago
Craig-Hallum
Craig-Hallum
Albert Lowe
100% 1-yr PVLA win rate
4 Dec ‘25 1 month ago
Stifel
Stifel
Annabel Samimy
100% 1-yr PVLA win rate
24 Nov ‘25 1 month ago
Raymond James
Raymond James
Ryan Deschner
100% 1-yr PVLA win rate
19 Nov ‘25 1 month ago
Cantor Fitzgerald
Cantor Fitzgerald
Josh Schimmer
100% 1-yr PVLA win rate
6 Nov ‘25 2 months ago